Therapeutic Areas

2025 Ophthalmology and Dermatology Surgical Lasers Sales and Rental: Leading Suppliers Revenue, Shares and Strategic Profiles

Fri, 29 Nov 2024 19:19:53 +0000

This new report from VPGMarketResearch.com provides the 2024 sales, market shares, and strategic profiles of major distributors of Medical Research and Clinical Lab Products.

The companies analyzed in the report include:

Agility Alcon/Novartis Alma Lasers/Sisram Bausch & Lomb Biolase Carl Zeiss Condela Cutera Cynosure Fortec Medical Fotona Healthtronics IPG Photonics Iridex J&J/Abbott Lensar Lumenis Lutronic MedLaserUSA Quantel/Ellex/Lumibird Syneron Candela Topcon Trimedyne Ziemer

Tables

2024 Ophthalmology Surgical Laser Market Sales and Shares of Major Suppliers

2024 Dermatology Surgical Laser Market Estimated Sales and Shares of Major Suppliers

2024 Surgical Laser Rental Market Estimated Sales and Shares of Major Suppliers

...

$950.00

Cardiovascular Diagnostic and Monitoring Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 16 Tests, Technology and Instrumentation Review

Tue, 18 Jul 2017 12:55:01 +0000

This new report from VPGMarketResearch provides analysis of the global cardiovascular diagnostic testing and monitoring market, including emerging tests, technologies, instrumentation, volume and sales segment forecasts for 16 tests by country, supplier shares and strategic profiles. ...

$4,500.00

Menopause Market Report 2023-2033

Fri, 26 May 2023 15:45:30 +0000

The Menopause Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population
Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.

Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women ...

$4,938.00

Vaccine Contract Manufacturing Market Report 2023-2033

Wed, 27 Dec 2023 14:49:55 +0000

The Vaccine Contract Manufacturing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Global Demand, Product Innovation and Cost Effectiveness Driving Market Growth
The global demand for vaccines has been rising due to various factors, including population growth, aging populations, and the emergence of infectious diseases. This increasing demand creates opportunities for contract manufacturers to support vaccine developers in meeting the production needs, especially during pandemics or widespread outbreaks. Advances in vaccine research and development have led to the discovery of new vaccines and improved formulations. Contract manufacturers play a crucial role in translating these innovations into commercial products. As vaccine developers focus on R&am...

$4,938.00

Allergy Diagnostics - Market Insights, Competitive Landscape and Market Forecast–2027

Thu, 27 Jul 2023 13:11:23 +0000

Allergy Diagnostics Market By Type (Products [Instruments And Consumables], And Services), By Allergy Type (Food Allergy, Drug Allergy, Inhalant Alllergy, And Others), By Diagnostic Test Type (In-Vivo And In-Vitro), By End User (Hospitals, Diagnostic Centers, And Others), by geography, is expected to grow at a significant CAGR forecast till 2026 due to the increasing incidence of various allergies such as food allergy and drug allergy as well as growing focus on developing innovative allergy diagnostic products The global allergy diagnositcs market was valued at USD 4.58 billion in 2020, growing at a CAGR of 11.78% during the forecast period from 2021 to 2026, to reach USD 8.93 billion by 2026. The allergy diagnostics market is gaining momentum owing to the rapidly rising incidence of allergic diseases. Moreover, increasing environmental pollution such as decreasing air quality in industrialized areas due to increasing air pollution is also a factor propelling the allergy diagnostics market. In addition, the technological advancements and the launch of new allergy diangostic tests...

$2,750.00

Women's Health Market Report 2023-2033

Fri, 19 May 2023 11:50:09 +0000

The Women's Health Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rise in support and initiatives by government and NGOs is boosting the market growth
Globally there has been a rise in awareness of women’s health with all the governments and NGOs supporting through various funding and awareness programs. For instance, in 2021, Office on Women’s Health (OWH) which works with the parent organisation i.e. The U.S. Department of Health and Human Services (HHS) announced an initiative to enhance and improve maternal health data across the country through a US$8 million agreement with Premier Inc. Under this agreement a minimum of 200 would be deployed under evidence based best practices for maternal care. On June 2022, the White House announced the Bide...

$4,938.00

Meningococcal Vaccines Market Report 2023-2033

Fri, 19 May 2023 11:50:09 +0000

The Meningococcal Vaccines Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Prevalence of Meningitis Driving Market Growth
Increasing adoption of meningococcal vaccines and the growing prevalence of meningitis and other viral diseases in developed as well as developing regions is anticipated to drive market growth. Also, the growing investment in R&D and novel drug launches for the treatment of viral diseases is further boosting the market growth. The developed regions including the U.S., Japan, and Europe accounted for a large share in the market is due to the well-developed healthcare infrastructure and better healthcare awareness in developed countries compared to developing countries. Thus, the demand for advanced and more efficient drugs is hig...

$4,938.00

Antibiotics Market Report 2023-2033

Fri, 19 May 2023 11:50:09 +0000

The Antibiotics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.

What Q...

$4,938.00

2022-2027 Gastrointestinal (GI) Diagnostic Testing Market: US, Europe, Japan--Test Volume and Sales Forecasts, Test Volume by Method (Molecular, Serology/Immunodiagnostics, Culture/Microscopy)

Mon, 22 Nov 2021 14:50:30 +0000

This new report from LeadingMarketResearch.com presents a seven-country strategic analysis of major business opportunities emerging in the GI disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales by country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

...

$4,500.00

Dermatological Drugs Market Report 2022-2032

Fri, 23 Dec 2022 15:52:52 +0000

The Dermatology Drugs Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors Such As the Impact of Skin Disease on Quality Of Life and the Resulting Need to Tackle This Are Driving the Market Growth
WHO (World Health Organization) defined it as disability in skin conditions that impact the well-being, mental health, ability to function, and social participation and restrict engagement with others. Quality of life (QoL) tools help in these and some of the tools include the Dermatology Life Quality Index (DLQI) and the Skindex. The QoL can be impaired for a variety of reasons mainly due to symptoms of the disease. Atopic eczema is one disease where the psychological burden is particularly pronounced. Psychosomatic involvement is the main characteristic of atopic...

$4,740.00

Dermatology CROs Market Report 2022-2032

Fri, 23 Dec 2022 15:52:52 +0000

The Dermatology CROs Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region.

Reduced market time, reduced infrastructure costs, and improved operational efficiency to drive the market growth
Reduced market time, infrastructure costs, and operational benefits are some of the major forces driving the dermatology CRO market. The expansion or localization of contract services by countries is expected to result in significant investments in facilities, equipment, and skilled labour. Furthermore, some countries with low resources are unable to manufacture vaccines due to a lack of equipment and experienced personnel. This causes the countries to create contracts with contract producers in order to meet the demands of the market.

Considering the COVID-19 pandemic, the co...

$4,740.00

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Mon, 26 Dec 2022 14:24:58 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus (RSV) Infections - Drugs In Development, 2022, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape.

Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing passages. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children less than one year of age. The symptoms of RSV infection include cough, stuffy or runny nose, mild sore throat, earache and fever. Treatment includes proper medication and hygiene practice.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Respiratory Syncytial Virus (RSV) Infections - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Respiratory Syncytial Virus (RSV) Infections (Infectious Disease), complete with analysis by stage of developme...

$2,500.00

Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Mon, 26 Dec 2022 14:24:58 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis (Gout) - Drugs In Development, 2022, provides an overview of the Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline landscape.

Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area and joint redness. Risk factors include obesity, high alcohol intake, injury to a joint, long-standing kidney disease and high intake of foods rich in purines.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gouty Arthritis (Gout) - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Gouty Arthritis (Gout) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action ...

$2,000.00

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Mon, 26 Dec 2022 14:24:58 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Drugs In Development, 2022, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) pipeline landscape.

Acute lymphocytic leukemia (ALL) is the cancer of the white blood cells due to the production of a large number of immature lymphocytes thus blocking the production of normal blood cells. It enters the blood stream and rapidly progress to other parts of the body such as spleen, lymph nodes and liver. Risk factors for ALL include exposure to radiation or chemicals, age, virus infections and genetic factors. Symptoms include anemia, frequent infections, easy bruising, bone pain and breathing problems. Treatment includes chemotherapy, transfusions, transplant and medications.c

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Drug...

$2,000.00

Antisense Oligonucleotide (ASO) Therapeutics Market Report 2022-2032

Mon, 26 Dec 2022 10:23:08 +0000

The antisense oligonucleotide therapeutics market was valued at US$17.46 billion in 2021 and is projected to grow at a CAGR of 13.71% during the forecast period 2022-2032....

$4,740.00

CAR-T Therapy Market Report 2022-2032

Mon, 26 Dec 2022 10:23:08 +0000

The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of 42.95% during the forecast period 2022-2032....

$4,740.00

United States Influenza Vaccines Market: Focus on Persons Vaccinated, Pricing, Production, Supply, Promising Influenza Vaccines, Clinical Trials, Regulatory, Reimbursement, Distribution Channel, Major Deals, Key Players, Recent Developments – Size, Shar

Fri, 21 Oct 2022 15:35:44 +0000

The United States Influenza Vaccines market size is expected to reach USD 7,007 million by 2030. It is expected to expand at a CAGR of 6.9% from 2021 to 2030. This new market report offerings an wide-ranging study of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report also provides up-to-date market size data for the period 2015 - 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for influenza vaccines. This Newest and Comprehensive United States Influenza Vaccines Market Research Report 2022 Delivers: The United States Influenza Vaccines Market Size, Insights, Analysis and Forecast,2015-2030 The United States Number of Persons Vaccinated with Influenza Vaccines and Forecast, 2015 - 2030 Analyzes the United States Children Being Vaccinated with Influenza Vaccines and Forecast,2015 - 2030 Analyzes the United States Adults Being Vaccinated with Influenza Vac...

$3,450.00

United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2028

Fri, 21 Oct 2022 15:35:44 +0000

Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. The prominent factors that are expected to contribute to the growth of the United States human vaccines market: • Increased Disease Awareness • Approval/launches of the New Vaccines • Rising Focus on Immunization Programs • Increasing Investments and Government Support for the Vaccines Development After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States human vaccines market are obtained with maximum precision. This new 2022 market report provides a holistic analysis of the entire United States human vaccines market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States’ human vaccines market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspec...

$2,699.00

Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2022, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape.

Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tissue, from treatments and diagnostic procedures, or from skin, nerve and other changes caused by either the body's immune response or hormones released by the tumor. Cancer pain can be treated by analgesic drug therapy, non-opioid analgesics, opioid analgesics, adjuvant drugs, psychotherapy, anesthetic and neurosurgical pain management.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cancer Pain - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Cancer Pain (Central Nervous System), complete with analysis by stage of development,...

$2,000.00

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Drugs In Development, 2022, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the head. These headaches are often associated with nausea, vomiting, and extreme sensitivity to light and sound. Symptoms include problems speaking, tingling in face, arms, and shoulders, pain behind one of the eyes and pain that gets worse with routine physical activity.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Migraine - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Migraine (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the ...

$2,000.00

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 21 Oct 2022 16:02:05 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Drugs In Development, 2022, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorganized speech and disorganized behavior. Risk factors include family history, age, drugs (psychoactive) and weakened immune system. Treatment includes antipsychotic medications.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Schizophrenia - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Schizophrenia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its...

$2,500.00

Vaccine Sales Market Report 2022-2032

Fri, 21 Oct 2022 15:17:16 +0000

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers. ...

$5,056.00

Vaccine Contract Manufacturing Market Report 2022-2032

Fri, 21 Oct 2022 15:17:16 +0000

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet...

$5,056.00

Plasma Protein Therapeutics Market Report 2022-2032

Fri, 21 Oct 2022 15:17:16 +0000

Global plasma protein therapeutics market is projected to reach a market value of US$59.58 billion in 2032....

$5,056.00

Respiratory Drug Delivery Technologies Market Report 2022-2032

Fri, 21 Oct 2022 15:17:16 +0000

The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032....

$5,056.00